Nagercoil Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.15 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.15 Cr
as on 16-11-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.76 Cr
as on 16-11-2024
- Revenue 36.39%
(FY 2023)
- Profit 18.80%
(FY 2023)
- Ebitda -2.08%
(FY 2023)
- Net Worth 142.01%
(FY 2023)
- Total Assets 6.16%
(FY 2023)
About Nagercoil Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.15 Cr and a paid-up capital of Rs 2.15 Cr.
The company currently has active open charges totaling ₹7.76 Cr.
Ramasamy Mohandhas, Chandrakasan Gauthaman, Jeyaharan Jeyaharan, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74900TN2012PTC083979
- Company No.
083979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2012
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanyakumari, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nagercoil Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeyaharan Jeyaharan  | Managing Director | 12-Jan-2012 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramasamy Mohandhas | Director | 12-Jan-2012 | Current |
| Chandrakasan Gauthaman | Director | 12-Jan-2012 | Current |
| Thanumalayaperumal Thiraviam | Director Appointed In Casual Vacancy | 31-Aug-2015 | Current |
| Mohandhas Ramnath | Director Appointed In Casual Vacancy | 31-Aug-2015 | Current |
| Jaya Gauthaman | Director Appointed In Casual Vacancy | 31-Aug-2015 | Current |
| Muthuretnam Thiagarajan | Director Appointed In Casual Vacancy | 31-Aug-2015 | Current |
Financial Performance of Nagercoil Diagnostics.
Nagercoil Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.39% increase. The company also saw a substantial improvement in profitability, with a 18.8% increase in profit. The company's net worth Soared by an impressive increase of 142.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nagercoil Diagnostics?
In 2023, Nagercoil Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sushrushah Medicare Centre Private LimitedActive 23 years 10 months
Ramasamy Mohandhas and Mohandhas Ramnath are mutual person
- Nagercoil Stone Clinic Private LimitedActive 19 years 3 months
Chandrakasan Gauthaman and Jeyaharan Jeyaharan are mutual person
- A To Z Health Care Solutions Private LimitedActive 4 years 4 months
Muthuretnam Thiagarajan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Aug 2016 | ₹7.16 Cr | Open |
Others Creation Date: 23 Mar 2016 | ₹6.00 M | Open |
How Many Employees Work at Nagercoil Diagnostics?
Nagercoil Diagnostics has a workforce of 12 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nagercoil Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nagercoil Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
